Here, this study reported for the first time that eIF3a expression is positively correlated with vemurafenib sensitivity in melanoma cells, and this effect of eIF3a is mediated by regulating the translation of the protein phosphatase PPP2R1B, which inhibits ERK phosphorylation. Here, PPP2R1B is linked to melanoma.